Inspire Medical Systems, Inc.
16
6
8
6
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 50/100
6.3%
1 terminated/withdrawn out of 16 trials
85.7%
-0.8% vs industry average
25%
4 trials in Phase 3/4
33%
2 of 6 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (16)
Inspire UAS High Apnea Hypopnea Index (AHI)/High Body Mass Index (BMI) Post-Approval Study
Role: lead
Effects of Hypoglossal Nerve Stimulation on Cognition and Language in Down Syndrome and Obstructive Sleep Apnea
Role: lead
EURO-STIM Registry
Role: lead
Adherence and Outcome of Upper Airway Stimulation (UAS) for OSA International Registry
Role: lead
Pediatric Down Syndrome Post-Approval Study
Role: lead
Pediatric Post-Approval Registry
Role: lead
Inspire® Post-Approval Study / Protocol Number 2014-001
Role: lead
The PREDICTOR Study: Assessing Diagnostic Predictors of Airway Collapse in Patients With Obstructive Sleep Apnea
Role: lead
Inspire Singapore Study
Role: lead
Obstructive Sleep Apnea Therapy by Stimulation of the Hypoglossal Nerve
Role: collaborator
Stimulation Therapy for Apnea: Reporting Thoughts
Role: collaborator
Inspire Home Study: Utilization of Home Monitoring During Therapy Optimization in Patients With an Inspire Upper Airway Stimulation System (Comparison of Home Sleep Testing vs. In-lab Polysomnography Testing)
Role: lead
A Pilot Study to Evaluate the Hypoglossal Nerve Stimulator in Adolescents With Down Syndrome and Obstructive Sleep Apnea
Role: collaborator
Inspire® Upper Airway Stimulation (UAS) System German Post-Market Study
Role: lead
Stimulation Therapy for Apnea Reduction (Www.theSTARtrial.Com)
Role: lead
Inspire® Upper Airway Stimulation System
Role: lead
All 16 trials loaded